Medical Journals

Angiotensin Ii, Interstitial Inflammation, and the Pathogenesis of Salt-sensitive Hypertension.

Authors:
  • Franco Martha
  • Martínez Flavio
  • Rodríguez-Iturbe Bernardo
  • Johnson Richard J
  • Santamaría José
  • Montoya Angélica
  • Nepomuceno Tomas
  • Bautista Rocío
  • Tapia Edilia
  • Herrera-Acosta Jaime

From: Department of Nephrology, Instituto Nacional de Cardiología I Ch, Mexico City, Mexico. marthafranco@lycos.com

American journal of physiology. Renal physiology

  • Publish Date: Dec 2006
  • ISSN: 0363-6127
  • Volume: 291
  • Issue: 6
  • Pages: F1281-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Franco Martha, Martínez Flavio, Rodríguez-Iturbe Bernardo, et al. Angiotensin Ii, Interstitial Inflammation, and the Pathogenesis of Salt-sensitive Hypertension.. Am. J. Physiol. Renal Physiol. Dec 2006;291:F1281-7

Abstract

Transient administration of ANG II causes persistent salt-sensitive hypertension associated with arteriolopathy, interstitial inflammation, and cortical vasoconstriction; blocking the vascular and inflammatory changes with mycophenolate mofetil (MMF) prevents vasoconstriction. While infiltrating leukocytes during the salt-sensitive hypertension phase express ANG II, the functional role of ANG II during this phase is not known. We examined the acute effect of candesartan on renal hemodynamics during the established salt-sensitive hypertensive phase and related these findings to direct measurement of intrarenal ANG II and inflammatory cells in rats previously exposed to ANG II with or without MMF treatment. Sham controls were also examined. The administration of ANG II, followed by exposure to high-salt diet, resulted in hypertension, cortical vasoconstriction, an increase in interstitial inflammatory cells (44.8 +/- 1.3 lymphocytes/mm2, and 30.8 +/- 1.2 macrophages/mm2 ANG II vs. 19.6 +/- 2 lymphocytes/mm2, and 22 +/- 0.7 macrophages/mm2 Sham), and increase in renal ANG II levels (1,358 +/- 74.6 pg/ml ANG II vs. 194 +/- 9.28 pg/ml Sham). Treatment with MMF during the administration of exogenous ANG II resulted in reduction in renal interstitial inflammation (19.7 +/- 0.9 lymphocytes/mm2 and 15.9 +/- 0.8 machophages/mm2), ANG II levels (436.9 +/- 52.29 pg/ml), cortical vasoconstriction, and stable blood pressure levels during the subsequent challenge with a high-salt diet. Acute administration of candesartan similarly reduced renal vasoconstriction and blood pressure. We conclude that the cortical vasoconstriction occurring with salt-sensitive hypertension following exposure to ANG II is mediated by intrarenal ANG II, related, at least in part, to the interstitial inflammation.

Mesh Headings (Keywords): Angiotensin II, Angiotensin II Type 1 Receptor Blockers, Animals, Benzimidazoles, Blood Volume, Hypertension, Renal, Lymphocytes, Macrophages, Male, Microcirculation, Nephritis, Rats, Rats, Sprague-Dawley, Renal Circulation, Sodium Chloride, Dietary, Tetrazoles, Vasculitis, Vasoconstrictor Agents


Check for Full Text / PubMed Unique Identifier (PMID): 16868307


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.